Keywords: Orphan drugs, Market forecasts, Roche, Rituxan Lucentis, Novartis

Global orphan drugs market led by Roche's rituximab

Article | 26 February 2013

Print This

The global orphan drugs market is estimated to have increased at a compound annual growth rate (CAGR) of 9.6% between 2005 and 2011, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in